We at Orphan Drug Consulting are pleased to announce that we will be hosting a Client Event in Zurich, Switzerland on December 3rd, 2024!
This is an opportunity to hear from industry experts on the complex topic of Managed Access Programs (MAPs), and learn more about the hidden impact of Brexit on Switzerland, all while growing your network and enjoying the winter festivities in the picturesque Zurich.
Some Workshop Takeaways
A better understanding of MAPs and key regulatory pathways
Strategies for balancing speed to market with compliance
Practical steps to implement MAPs effectively
Insights from successful, real-world applications
Who Should Attend
Current Orphan Drug Consulting Clients
Industry Stakeholders
Supply Chain, Regulatory, Commercial and Quality Leads
Anyone Currently Managing Navigating an MAP!
To register your interest, please email [email protected]. Spaces are limited and filling up fast.
Remember, any product provided to a patient outside of its marketing authorisation or clinical trial framework falls under the scope of a Managed Access Program!
